Watson, the television game show-playing supercomputer from IBM, is teaming up with health insurer WellPoint to assist medical professionals in diagnosing and treating patients.

IBM and WellPoint announced they have agreed to develop the first commercial application for the computer which defeated two human champions on the popular television game show Jeopardy! in February.

“Watson is expected to serve as a powerful tool in the physician’s decision making process,” the New York-based IBM and Indiana-based WellPoint said in a statement.

WellPoint, which has 34 million members, said it will “develop and launch Watson-based solutions to help improve patient care” and IBM will supply the Watson technology powering the health care products.

Jeopardy! tests a player’s knowledge in a range of categories, from geography to politics to history to sports and entertainment.

Watson, which understands spoken language, uses what IBM calls Question Answering technology to tackle Jeopardy! clues, gathering evidence, analysing it at dizzying speeds and then scoring and ranking the most likely answer.

“Imagine having the ability to take in all the information around a patient’s medical care – symptoms, findings, patient interviews and diagnostic studies,” WellPoint chief medical officer Sam Nussbaum said.

“Then, imagine using Watson analytic capabilities to consider all of the prior cases, the state-of-the-art clinical knowledge in the medical literature and clinical best practices to help a physician advance a diagnosis and guide a course of treatment.”

Watson, named after IBM founder Thomas Watson, can rifle through 200 million pages of data and provide precise responses in just seconds.

“Watson’s ability to analyse the meaning and context of human language, and quickly process vast amounts of information to suggest options targeted to a patient’s circumstances, can assist decision makers, such as physicians and nurses, in identifying the most likely diagnosis and treatment options for their patients,” IBM and WellPoint said.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.